NCT05515081View on ClinicalTrials.gov

Antibody Response and Longevity Post SARS-CoV-2 Vaccine (SARS-AB)

NACompletedINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

May 21, 2021

Primary Completion Date

May 21, 2022

Study Completion Date

May 21, 2023

Conditions

Vaccine Reaction

Interventions

PROCEDURE

blood sample collection

blood sample colletion at regular intervals

Trial Locations (1)

Unknown

IRCCS San Camillo, Venice-Lido

All Listed Sponsors

lead

IRCCS San Camillo, Venezia, Italy

OTHER